Published in Infect Immun on December 01, 1991
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes. Cell Host Microbe (2015) 1.48
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect Immun (2009) 1.36
Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest (2000) 1.27
Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect Immun (1995) 1.19
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun (1992) 1.06
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest (2005) 1.06
Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02
Biological function and molecular mapping of M antigen in yeast phase of Histoplasma capsulatum. PLoS One (2008) 1.01
Fungal cell wall vaccines: an update. J Med Microbiol (2012) 0.91
Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect Immun (2001) 0.91
Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality. Infect Immun (2011) 0.90
Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Mycopathologia (2011) 0.89
Histoplasma capsulatum heat-shock 60 orchestrates the adaptation of the fungus to temperature stress. PLoS One (2011) 0.82
A deficiency in gamma interferon or interleukin-10 modulates T-Cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun (2005) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods Enzymol (1983) 12.78
Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med (1987) 2.87
Removal of sodium dodecyl sulfate from proteins by ion-pair extraction. Methods Enzymol (1983) 1.98
Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages. J Immunol (1984) 1.97
Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun (1988) 1.68
Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA). J Immunol (1984) 1.63
The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping of superoxide anion. J Immunol (1990) 1.24
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun (1991) 1.16
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect Immun (1971) 1.15
Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J Infect Dis (1978) 1.04
Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect Immun (1988) 0.99
Survival of Histoplasma capsulatum in experimental histoplasmosis in mice. Proc Soc Exp Biol Med (1956) 0.96
Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas. Infect Immun (1990) 0.92
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol (1998) 1.75
Role of L3T4+ T cells in host defense against Histoplasma capsulatum. Infect Immun (1988) 1.68
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A (1997) 1.59
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Treatment of carotid cavernous fistulas using covered stents: midterm results in seven patients. AJNR Am J Neuroradiol (2007) 1.40
Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol (1993) 1.39
Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis (1997) 1.39
Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun (1998) 1.32
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis (2008) 1.27
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination. J Neurosci (1997) 1.15
Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol (2000) 1.10
Medical mycology in crisis. J Lab Clin Med (1983) 1.06
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun (1992) 1.06
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Murine model of paracoccidioidomycosis. Production of fatal acute pulmonary or chronic pulmonary and disseminated disease: immunological and pathological observations. J Exp Pathol (1984) 1.04
Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol (1998) 1.03
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun (1999) 1.02
Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action. Br J Pharmacol (2010) 0.99
Characterization of antigenic determinants in histoplasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infect Immun (1988) 0.98
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun (1996) 0.97
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol (1988) 0.95
Development of vaccines and their use in the prevention of fungal infections. Med Mycol (1998) 0.94
V beta 6+ and V beta 4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J Immunol (2001) 0.93
Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun (2006) 0.93
Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect Immun (1999) 0.90
Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. J Immunol (1984) 0.90
Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia. Infect Immun (2007) 0.90
Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb Pathog (2000) 0.90
Allelic variants of acetylcholinesterase: genetic evidence that all acetylcholinesterase forms in avian nerves and muscles are encoded by a single gene. Proc Natl Acad Sci U S A (1988) 0.88
Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia. Antimicrob Agents Chemother (2009) 0.88
Molecular cloning, characterization and expression of the heat shock protein 60 gene from the human pathogenic fungus Paracoccidioides brasiliensis. Med Mycol (2001) 0.88
Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun (1993) 0.86
Unexplained fever in burn patients due to cytomegalovirus infection. JAMA (1982) 0.84
Fulminant wound infection with Aeromonas hydrophila. South Med J (1980) 0.83
Recognition of Histoplasma capsulatum yeast-cell antigens by human lymphocytes and human T-cell clones. J Leukoc Biol (1992) 0.83
Immunomodulation in the mycoses. J Med Vet Mycol (1992) 0.82
Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosis. Infect Immun (1983) 0.81
Generation of disparate immunoregulatory factors in two inbred strains of mice with disseminated histoplasmosis. J Immunol (1982) 0.81
Substance use among university students at the St Augustine campus of the University of the West Indies. West Indian Med J (2010) 0.81
Requirements for histoplasmin presentation by accessory cells to a Histoplasma capsulatum-reactive T-cell line. J Leukoc Biol (1989) 0.80
Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.80
Detection of histoplasmal antigens in mice undergoing experimental pulmonary histoplasmosis. Am Rev Respir Dis (1985) 0.80
Infection with Histoplasma capsulatum: Host-fungus interface. Rev Iberoam Micol (1998) 0.80
Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum. Infect Immun (2000) 0.80
Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol (1998) 0.80
A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. Genet Test (2000) 0.79
Evolution of inflammatory response and cellular immune responses in a murine model of disseminated blastomycosis. Infect Immun (1985) 0.79
Impairment of granulomatous inflammatory response to Histoplasma capsulatum by inhibitors of angiotensin-converting enzyme. Infect Immun (1985) 0.78
Tooth scaling and evolutionary dwarfism: an investigation of allometry in human pygmies. Am J Phys Anthropol (1988) 0.78
Atypical mycobacterial lymphadenitis in an adult. Chest (1980) 0.77
Early detection of HIV-1 in men from Kenya using a synthetic peptide and a p24 antigen enzyme-linked immunosorbent assay. AIDS (1994) 0.76
New perspectives on the key role of calcium in the progression of heart disease. J Muscle Res Cell Motil (2003) 0.76
Epidural blood patch does cause a decrease in heart rate. Anesth Analg (1992) 0.75
Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate. Ann Pharmacother (1997) 0.75
Simplified technique for subarachnoid anesthesia. Reg Anesth (1992) 0.75
Resolution of influenzal pneumonia. IMJ Ill Med J (1980) 0.75
Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma. Prostate (1989) 0.75
Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans. Med Mycol (1998) 0.75
[Significance of lymphocytotoxic antibodies in kidney transplantation revisited (author's transl)]. Nouv Presse Med (1981) 0.75